OrbiMed leads $70M raise for Harpoon Therapeutics; Ziopharm inks combo deal with Regeneron's PD-1
→ OrbiMed has led the syndicate for a $70 million Series C round for Harpoon Therapeutics. The new money will be put …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
